NDC 70010-013 – Methylphenidate Hydrochloride
Methylphenidate Hydrochloride 20 mg/1 · Capsule, Extended Release · Oral
Product NDC70010-013
Product details
- Brand name
- Methylphenidate Hydrochloride
- Generic name
- Methylphenidate Hydrochloride
- Labeler
- Granules Pharmaceuticals Inc.
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA211796
- Marketed since
- September 10, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Central Nervous System Stimulant
Active ingredients
- Methylphenidate Hydrochloride 20 mg/1
Uses, dosage, side effects and warnings for Methylphenidate Hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70010-013-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70010-013-01) | Sep 10, 2019 |
Other Methylphenidate Hydrochloride products
- 16729-479 Methylphenidate Hydrochloride 10 mg/1 · Tablet · Accord Healthcare, Inc.
- 16729-480 Methylphenidate Hydrochloride 20 mg/1 · Tablet · Accord Healthcare, Inc.
- 16729-478 Methylphenidate Hydrochloride 5 mg/1 · Tablet · Accord Healthcare, Inc.
- 0591-3895 Methylphenidate Hydrochloride 50 mg/1 · Capsule, Extended Release · Actavis Pharma, Inc.
- 0591-3902 Methylphenidate Hydrochloride 60 mg/1 · Capsule, Extended Release · Actavis Pharma, Inc.
- 62037-725 Methylphenidate Hydrochloride 18 mg/1 · Tablet, Film Coated, Extended Release · Actavis Pharma, Inc.
- 62037-726 Methylphenidate Hydrochloride 36 mg/1 · Tablet, Film Coated, Extended Release · Actavis Pharma, Inc.
- 0591-3891 Methylphenidate Hydrochloride 40 mg/1 · Capsule, Extended Release · Actavis Pharma, Inc.
- 0591-3873 Methylphenidate Hydrochloride 30 mg/1 · Capsule, Extended Release · Actavis Pharma, Inc.
- 0591-3854 Methylphenidate Hydrochloride 10 mg/1 · Capsule, Extended Release · Actavis Pharma, Inc.
- 0591-3869 Methylphenidate Hydrochloride 20 mg/1 · Capsule, Extended Release · Actavis Pharma, Inc.
- 0591-3862 Methylphenidate Hydrochloride 15 mg/1 · Capsule, Extended Release · Actavis Pharma, Inc.